Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
NEW YORK (Reuters Health) – As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase…
NEW YORK (Reuters Health) – Both progression-free and overall survival are extended in patients with advanced non-small cell lung cancer treated with erlotinib following standard chemotherapy, according to…
NEW YORK (Reuters Health) – Due to hemoglobin degradation, delayed return of fecal occult blood tests (FOBTs) may miss colorectal adenomas and possibly also overt malignancy, according to…
NEW YORK (Reuters Health) – INR testing intervals of 4 weeks or less are typically recommended for patients on long-term warfarin therapy, but new research suggests that less…
NEW YORK (Reuters Health) – Allogeneic blood transfusions in patients who undergo coronary artery bypass graft surgery (CABG) substantially increase the patient’s odds of nosocomial infection, hospital readmission…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses percutaneous mitral valve replacement, which is more challenging than aortic valve replacement, using a mitral valve clip called…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses catheter-based aortic valve replacement and the Partner trial, which is studying the outcomes of surgery versus catheter or…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses anticoagulation for patients with mechanical valves, highlighting the use of the antithrombotics aspirin and clopidogrel for some patients…
NEW YORK (Reuters Health) – Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetes, new research shows. By contrast, treatment with…
Welcome to the world’s first film festival dedicated to raising awareness about the impact of prostate cancer on the ‘whole man’ mind, body and spirit. Being diagnosed with…
